A PHASE 2, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, DOSE-RANGING STUDY OF DRM01B TOPICAL GEL IN SUBJECTS WITH ACNE VULGARIS

Registry ID
DRM01B-ACN02
Source registry
HEALTH_CANADA
Status
Ongoing
Phase
PHASE2
Study type
INTERVENTIONAL
Sponsor
DERMIRA INCORPORATED
Start date
2015-04-11
Last update
2015-03-12

Conditions

Related clinical trials

View on source registry